Key Points Pfizer and Novo Nordisk have underperformed the market over the past year.But both should remain major players in ...

Stay updated with real-time stock market news, Sensex & Nifty movements, top gainers and losers, expert analysis, IPO updates ...

In July 2025, global markets have been navigating a complex landscape marked by new U.S. tariff announcements and mixed economic signals, with the Nasdaq Composite Index showing resilience amidst ...

Sarepta Therapeutics is laying off 500 staffers, or 36% of its workforce, as part of a strategic restructuring aiming to save $400 million annually. | Sarepta Therapeutics has laid off 500 staffers, ...

Australian shares have rebounded impressively since April, but the real test will be the upcoming earnings season.

These ASX 100 shares could rise in July after a very different past year. Here's what to consider about the two.

U.S. Bancorp notched a rise in earnings for the latest quarter as it benefited from a lower loan-loss provision and growth in fee income. The healthcare-products maker trimmed and narrowed its ...

Bourse ends at record in strongest session in three months. BHP rallies as CEO says China demand ‘resilient’. CSL posts its ...

U.S. stock futures were flat in early Thursday trading, signaling a muted open as investors digest a wave of mixed economic data, fresh earnings results, and heightened political drama involving ...

If you're looking for stocks that can make dramatic movements in a short time frame, the biotechnology space has what you ...

Every so often, activist investors swarm around underperforming companies in a certain industry and pressure them to change ...

One of these stocks finished the first half unchanged, and the other fell in the double-digits. Both represent great ...